Discussing Real-World Experience of Successes, Failures and Challenges: De‑Risking CMC for Bispecific & Multispecific Antibodies Through Early Developability‑Led Design

Discussing Real-World Experience of Successes, Failures and Challenges: De‑Risking CMC for Bispecific & Multispecific Antibodies Through Early Developability‑Led Design

2:55 pm - Tuesday 15th September 2026